Filed under: Deals

So this week, Merz Pharma Group, a major company in Germany, agreed to pay $253 million for BioForm Medical (BFRM). In fact, the premium came to 60% or $5.45. Keep in mind that the stock price was as low as $0.76 during the past year.
Continue reading BioForm Gets a Healthy Buyout from Merz Pharma
BioForm Gets a Healthy Buyout from Merz Pharma originally appeared on BloggingStocks on Mon, 04 Jan 2010 17:30:00 EST. Please see our terms for use of feeds.
Permalink | Email this | Comments






Full story at http://www.pheedcontent.com/click.phdo?i=9c954b6d57e934ccdb698d28691bd858
No comments:
Post a Comment